Market revenue in 2023 | USD 352.2 million |
Market revenue in 2030 | USD 527.0 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Lower extremity implants |
Fastest growing segment | Dental |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Lower Extremity Implants, Spinal Implants, Dental, Upper Extremity Implants |
Key market players worldwide | Medtronic PLC, Johnson & Johnson, Stryker Corp, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, NuVasive, Globus Medical Inc Class A, Arthrex, Enovis Corp, MicroPort Scientific Corp, ConforMIS, Exactech, Invibio, B. Braun, Acumed, Alphatec Holdings Inc, Integra Lifesciences Holdings Corp, Corin Group, Medacta Group SA Ordinary Shares, OrthoPediatrics Corp, Orthofix Medical Inc, FH Orthopedics, Enovis |
Lower extremity implants was the largest segment with a revenue share of 52.75% in 2023. Horizon Databook has segmented the Australia orthopedic implants market based on lower extremity implants, spinal implants, dental, upper extremity implants covering the revenue growth of each sub-segment from 2018 to 2030.
The orthopedic implants market in Australia is expected to exhibit significant growth in the coming years, driven by factors such as the increasing prevalence of osteoporosis & other orthopedic conditions and the growing demand for their treatment.
For instance, statistics from Osteoporosis Solutions Australia reveal a rising rate of fractures in the country from 2013 to 2022. Furthermore, poor bone health is a factor contributing to market growth. As per Osteoporosis Solutions Australia estimates, approximately 183,105 fractures are due to happen as a result of osteoporosis and osteopenia.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account